- Home
- RLAY vs IIIN Comparison
RLAY vs IIIN Comparison
Compare RLAY & IIIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- IIIN
- Stock Information
- Founded
- RLAY 2015
- IIIN 1953
- Country
- RLAY United States
- IIIN United States
- Employees
- RLAY N/A
- IIIN N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- IIIN Steel/Iron Ore
- Sector
- RLAY Health Care
- IIIN Industrials
- Exchange
- RLAY Nasdaq
- IIIN Nasdaq
- Market Cap
- RLAY 619.0M
- IIIN 712.0M
- IPO Year
- RLAY 2020
- IIIN N/A
- Fundamental
- Price
- RLAY $4.12
- IIIN $38.90
- Analyst Decision
- RLAY Strong Buy
- IIIN
- Analyst Count
- RLAY 13
- IIIN 0
- Target Price
- RLAY $18.00
- IIIN N/A
- AVG Volume (30 Days)
- RLAY 1.5M
- IIIN 103.6K
- Earning Date
- RLAY 11-05-2025
- IIIN 10-16-2025
- Dividend Yield
- RLAY N/A
- IIIN 2.88%
- EPS Growth
- RLAY N/A
- IIIN 53.01
- EPS
- RLAY N/A
- IIIN 1.59
- Revenue
- RLAY $8,355,000.00
- IIIN $604,566,000.00
- Revenue This Year
- RLAY $31.55
- IIIN $24.62
- Revenue Next Year
- RLAY N/A
- IIIN $7.01
- P/E Ratio
- RLAY N/A
- IIIN $24.46
- Revenue Growth
- RLAY N/A
- IIIN 9.44
- 52 Week Low
- RLAY $1.78
- IIIN $22.49
- 52 Week High
- RLAY $10.72
- IIIN $41.64
- Technical
- Relative Strength Index (RSI)
- RLAY 65.83
- IIIN 60.69
- Support Level
- RLAY $3.52
- IIIN $37.29
- Resistance Level
- RLAY $4.26
- IIIN $39.20
- Average True Range (ATR)
- RLAY 0.22
- IIIN 0.88
- MACD
- RLAY 0.07
- IIIN 0.10
- Stochastic Oscillator
- RLAY 85.26
- IIIN 77.74
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About IIIN Insteel Industries Inc.
Insteel Industries Inc manufactures steel wire reinforcing products for concrete construction applications. It manufactures and markets PC strand and welded wire reinforcement, including ESM, concrete pipe reinforcement, and standard welded wire reinforcement. The company's products are sold to manufacturers of concrete products that are used in nonresidential construction. Its concrete reinforcing products consist of two product lines: PC strand and WWR. Insteel generates its geographical revenue from the United States.